This study aimed to investigate whether aCL IgG elevation in hemodialysis (HD) patients is associated with combined diabetes-hypertension (DM + HTN) etiology and thrombocytopenia, thereby identifying a clinically distinct potential high-risk subgroup. The gene discussed is ACLY; the disease is Thrombocytopenia.